Skip to content

Total Assets at other companies

Pfizer logo
PfizerPFE
$207.62B-0.2%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$200.89B+3.7%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$40.87B+8.9%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
$646.64M+113%
Krystal Biotech, Inc. logo
Krystal Biotech, Inc.KRYS
$1.4B+30.0%
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX

Other financials

Income statement

See full
Revenue$34.4M+55.5%
Operating income-$84.2M-13.1%
Net income-$69.2M-5.6%
EPS (diluted)-$0.71+13.4%

Balance sheet

See full
Cash & equivalents$144.1M+60.2%
Total debt$82.2M-6.5%
Total equity$1.5B+95.8%

Cash flow

See full
Operating cash flow-$88.8M-12.2%
CapEx$434.0K-7.1%
Free cash flow-$89.3M-12.1%

Valuation

See full
Market cap$7.44B+283%
Enterprise value$7.38B+280%
P/S144.5×+111×

Profitability

See full
Operating margin-697.7%+635pp
Net margin-612%+602pp
FCF margin-474%+92.4pp

Returns & leverage

See full
Return on equity-27.1%-3.7pp
Debt / equity0.1×-0.1×
Current ratio10.8×+2.3×

Where this comes from

Reported directly by Kymera Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The official record: Kymera Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kymera Therapeutics's total assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Kymera Therapeutics's total assets?
Kymera Therapeutics (KYMR) reported total assets of $1.67B in Q1 2026.
How has Kymera Therapeutics's total assets changed year-over-year?
Kymera Therapeutics's total assets increased by 81.7% year-over-year, from $918.31M to $1.67B.
What is the long-term trend for Kymera Therapeutics's total assets?
Over 5 years (2020 to 2025), Kymera Therapeutics's total assets has grown at a 29.0% compound annual growth rate (CAGR), from $487.18M to $1.74B.
What does total assets mean?
The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.